FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental NDA for ALEVE GELCAPS (naproxen sodium) by Bayer HealthCare LLC. The approval adds a gel-cap dosage form for this NSAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• ALEVE GELCAPS (NAPROXEN SODIUM)

Snippet

SUPPL AP for ALEVE GELCAPS (NAPROXEN SODIUM)